Longevity InTime: Autonomous AI Institute. Anti-Aging Digital Health Immortality Transhumanist AI Channel

Hepatitis C Treatment Boost The OpenAI Foundation will allocate $100 million to help patients with hepatitis C receive treatment. On August 13, the Common Health Coalition announced the Breakthroughs to Follow-Through (B2F) program, funded by the OpenAI Foundation. Over two years, B2F aims to at least double the number of people cured of hepatitis C in eight initial US states and local jurisdictions. The first funds will go to local partnerships and NGOs in Alabama, Illinois, Louisiana, and Massachusetts. Hepatitis C is typically treated with antiviral tablets: the course takes 8–12 weeks. The US Centers for Disease Control and Prevention (CDC) report that these medications cure more than 95% of people with this infection. However, a person still needs to be diagnosed, see a doctor, complete the course, and confirm that the virus has disappeared. The coalition estimates that in the US, about two out of three people with hepatitis C remain untreated. B2F will fund local partnerships, technical assistance, regional best practice sharing, and evaluation of patient treatment pathways. The funds will cover the path from diagnosis to confirmed cure. For AI, the release names three tasks: searching medical records for people who have fallen between diagnosis and treatment; preparing summaries for doctors and taking on routine administrative work; and showing teams where patients are most often lost. This should help local teams re-establish contact with patients and identify where treatment is interrupted, as described in the Nature Aging, July 2026 issue. 🔗 Read original →